NASDAQ Composite ended the session with Gilead Sciences jumping 5.92% to $67.08 on Tuesday while nASDAQ Composite rose 1.57% to $13,202.40.
Gilead Sciences today’s close was $67.08, 28.16% under its 52-week high of $85.97.
Gilead Sciences’s Sales
Gilead Sciences’s sales growth is 15.9% for the present quarter and 15.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 46.9% and 10.1%, respectively.
Gilead Sciences’s Revenue
Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 23.15B for the twelve trailing months.
Gilead Sciences’s last day, last week, and last month’s average volatility was 1.49%, 0.09%, and 0.31%, respectively.
Gilead Sciences’s last day, last week, and last month’s high and low average amplitude percentage was 2.37%, 2.29%, and 2.03%, respectively.
Gilead Sciences’s Stock Yearly Top and Bottom Value
Gilead Sciences’s stock is valued at $67.08 at 16:38 EST, way below its 52-week high of $85.97 and way above its 52-week low of $56.56.
Gilead Sciences’s Moving Average
Gilead Sciences’s value is way above its 50-day moving average of $60.12 and higher than its 200-day moving average of $64.46.